Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 28 studies | 30% ± 12% | |
conventional dendritic cell | 20 studies | 28% ± 12% | |
mast cell | 13 studies | 27% ± 8% | |
dendritic cell | 12 studies | 25% ± 13% | |
microglial cell | 12 studies | 39% ± 15% | |
type I pneumocyte | 11 studies | 29% ± 10% | |
myeloid cell | 10 studies | 30% ± 9% | |
epithelial cell | 8 studies | 33% ± 16% | |
basal cell | 7 studies | 37% ± 24% | |
renal alpha-intercalated cell | 7 studies | 61% ± 10% | |
hematopoietic stem cell | 6 studies | 30% ± 7% | |
alveolar macrophage | 5 studies | 21% ± 4% | |
mononuclear phagocyte | 5 studies | 21% ± 6% | |
ciliated cell | 5 studies | 28% ± 14% | |
mesothelial cell | 5 studies | 38% ± 16% | |
keratinocyte | 5 studies | 23% ± 4% | |
ionocyte | 4 studies | 27% ± 13% | |
renal beta-intercalated cell | 4 studies | 76% ± 7% | |
squamous epithelial cell | 3 studies | 44% ± 16% | |
monocyte | 3 studies | 28% ± 3% | |
tissue-resident macrophage | 3 studies | 19% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 4 studies | 27% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 96% | 1461.84 | 85 / 89 | 97% | 40.40 | 871 / 901 |
lung | 96% | 1103.50 | 555 / 578 | 93% | 29.28 | 1074 / 1155 |
intestine | 57% | 976.99 | 549 / 966 | 97% | 33.70 | 510 / 527 |
bladder | 67% | 575.38 | 14 / 21 | 87% | 26.21 | 437 / 504 |
esophagus | 58% | 2047.12 | 845 / 1445 | 95% | 42.34 | 173 / 183 |
stomach | 42% | 209.29 | 149 / 359 | 93% | 29.18 | 267 / 286 |
pancreas | 41% | 224.79 | 133 / 328 | 94% | 46.88 | 167 / 178 |
skin | 74% | 3934.87 | 1342 / 1809 | 49% | 9.13 | 230 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 95.89 | 29 / 29 |
breast | 19% | 97.36 | 88 / 459 | 79% | 14.23 | 888 / 1118 |
spleen | 98% | 1920.85 | 237 / 241 | 0% | 0 | 0 / 0 |
prostate | 63% | 397.51 | 155 / 245 | 30% | 2.97 | 149 / 502 |
brain | 16% | 103.49 | 422 / 2642 | 76% | 16.36 | 539 / 705 |
thymus | 17% | 86.72 | 108 / 653 | 76% | 15.86 | 459 / 605 |
tonsil | 0% | 0 | 0 / 0 | 91% | 22.45 | 41 / 45 |
ovary | 2% | 8.91 | 4 / 180 | 86% | 17.79 | 370 / 430 |
uterus | 5% | 91.17 | 8 / 170 | 80% | 29.32 | 366 / 459 |
adipose | 65% | 726.37 | 780 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 38% | 196.07 | 99 / 258 | 10% | 2.58 | 23 / 230 |
peripheral blood | 45% | 265.27 | 421 / 929 | 0% | 0 | 0 / 0 |
liver | 5% | 27.84 | 12 / 226 | 31% | 14.59 | 125 / 406 |
blood vessel | 22% | 125.46 | 296 / 1335 | 0% | 0 | 0 / 0 |
muscle | 19% | 109.79 | 149 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 6% | 0.65 | 5 / 80 |
heart | 6% | 32.22 | 48 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010744 | Biological process | positive regulation of macrophage derived foam cell differentiation |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0070328 | Biological process | triglyceride homeostasis |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_0042104 | Biological process | positive regulation of activated T cell proliferation |
GO_0001525 | Biological process | angiogenesis |
GO_0042092 | Biological process | type 2 immune response |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_2000556 | Biological process | positive regulation of T-helper 1 cell cytokine production |
GO_0006954 | Biological process | inflammatory response |
GO_0008283 | Biological process | cell population proliferation |
GO_0061436 | Biological process | establishment of skin barrier |
GO_0030431 | Biological process | sleep |
GO_0032819 | Biological process | positive regulation of natural killer cell proliferation |
GO_0045662 | Biological process | negative regulation of myoblast differentiation |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0032736 | Biological process | positive regulation of interleukin-13 production |
GO_0030101 | Biological process | natural killer cell activation |
GO_0034105 | Biological process | positive regulation of tissue remodeling |
GO_0007267 | Biological process | cell-cell signaling |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0042267 | Biological process | natural killer cell mediated cytotoxicity |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0042088 | Biological process | T-helper 1 type immune response |
GO_0032725 | Biological process | positive regulation of granulocyte macrophage colony-stimulating factor production |
GO_0051142 | Biological process | positive regulation of NK T cell proliferation |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0035655 | Biological process | interleukin-18-mediated signaling pathway |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_0150078 | Biological process | positive regulation of neuroinflammatory response |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0030155 | Biological process | regulation of cell adhesion |
GO_0032740 | Biological process | positive regulation of interleukin-17 production |
GO_0042119 | Biological process | neutrophil activation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0045630 | Biological process | positive regulation of T-helper 2 cell differentiation |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005829 | Cellular component | cytosol |
GO_0045515 | Molecular function | interleukin-18 receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | IL18 |
Protein name | Interleukin-18 (IL-18) (Iboctadekin) (Interferon gamma-inducing factor) (IFN-gamma-inducing factor) (Interleukin-1 gamma) (IL-1 gamma) Interleukin-18 (IL-18) |
Synonyms | IL1F4 IGIF |
Description | FUNCTION: Pro-inflammatory cytokine primarily involved in epithelial barrier repair, polarized T-helper 1 (Th1) cell and natural killer (NK) cell immune responses . Upon binding to IL18R1 and IL18RAP, forms a signaling ternary complex which activates NF-kappa-B, triggering synthesis of inflammatory mediators . Synergizes with IL12/interleukin-12 to induce IFNG synthesis from T-helper 1 (Th1) cells and natural killer (NK) cells . Involved in transduction of inflammation downstream of pyroptosis: its mature form is specifically released in the extracellular milieu by passing through the gasdermin-D (GSDMD) pore . . FUNCTION: Pro-inflammatory cytokine primarily involved in epithelial barrier repair, polarized T-helper 1 (Th1) cell and natural killer (NK) cell immune responses. Upon binding to IL18R1 and IL18RAP, forms a signaling ternary complex which activates NF-kappa-B, triggering synthesis of inflammatory mediators. Synergizes with IL12/interleukin-12 to induce IFNG synthesis from T-helper 1 (Th1) cells and natural killer (NK) cells. Involved in transduction of inflammation downstream of pyroptosis: its mature form is specifically released in the extracellular milieu by passing through the gasdermin-D (GSDMD) pore. . |
Accessions | ENST00000524595.5 [Q14116-2] ENST00000280357.12 [Q14116-1] B0YJ28 ENST00000528832.1 [Q14116-1] Q14116 |